Awareness Webinars
Learn about the unique features offered by Omnipod 5 that can benefit a variety of people living with type 1 diabetes.
Dr. Guido Freckmann (Germany)
Renowned researcher in sensor technology.
John Pemberton (United Kingdom)
Experienced clinician offering practical insights.
Is 70% TIR Really 70%? Understanding CGM Measurements and Analysing the Data
Automated Insulin Delivery (AID) systems depend on precise sensor performance to achieve Time in Range (TIR) targets. In this webinar, we’ll dive into the latest research on sensor accuracy and performance, equipping you with the tools to critically evaluate the data. By the end of the session, you’ll understand how to critically analyze the data you encounter on AID system and compare TIR results with HbA1c values—an essential skill for optimizing long-term patient outcomes.
Don’t miss this opportunity to deepen your knowledge and improve patient care.
Date: January 2026
Duration: 1hr
Karen McAssey (CA)
Yael Lebenthal (IS)
Get the Most Out of Omnipod® 5 for Your Pediatric Patient Population
This engaging and insightful interactive workshop explored how the Omnipod® 5 Automated Insulin Delivery System is transforming care for paediatric patients with diabetes. What was covered:
- Latest paediatric results from RADIANT
- Practical guidance to optimise settings
- Challenging clinical scenarios and how Omnipod 5 is helping deliver successful outcomes
- The future of data management
Date: November 2025
Duration: 1 hr
Dr. Dessi Zaharieva
Stanford University, USA
Dr. Michael Riddell
York University, Canada
Practical Implementation of Automated Insulin Delivery (AID) and Exercise Guidance
Learn how automated insulin delivery (AID) systems like Omnipod® 5 can help healthcare providers (HCPs) and people with diabetes navigate these challenges more effectively
Date: May 2025
Duration: 1hr
The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intentended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog® / NovoRapid®, Humalog®, Admelog®/Insulin lispro Sanofi®, Trurapi/Insulin aspart Sanofi®, and Kirsty®. Refer the Omnipod® 5 Automated Insulin Delivery System User Guide for complete safety information including indications, contraindications, warnings, cautions, and instructions.
Dr. Bernard Gehr,
Diabetologist BLÄK + DDG, Senior Physician in Internal Medicine, Diabetes and Metabolism, Germany
Dr. Inge Van Boxealer,
Endocrinologist, General Hospital St. Lucas, Belgium
Dr. Fiona Campbell, OBE, MD, FRCPCH
Consultant in Children & Young People’s Diabetes Care, St James Hospital, UK
Understanding Omnipod® 5 and Strategies for Success
Review clinical data supporting the use of Omnipod 5 in broad populations, overview the algorithm and system functionality, and examine clinical case examples from the panelists’ practices.
Date: March 2025
Duration: 1hr
Prof. Pratik Choudhary
Professor/ Honorary Consultant in Diabetes, UK
Dr. Winfried Keuthage
Diabetologist DDG
Germany
John Pemberton
Registered Dietitian & Diabetes Educator
UK
Gain Clinical Efficiencies with Simple to Use Automated Insulin Delivery Technology
Hear about the AID Consensus Guidance on training and education for AID technology, the latest data on virtual learning, and how to gain efficiencies in your clinic using Omnipod 5.
Date: February 2025
Duration: 1hr